News - Boston Scientific EMEA

EMEA Newsroom

Welcome to our newsroom for the Europe, Middle East & Africa region.

Featured Stories

May 12, 2023

Partnering with Hertfordshire Mind Network to enhance mental wellbeing

May 9, 2023

Clare Brooke Appointed Sustainability Lead For EMEA Region

Apr 19, 2023

Five ways Boston Scientific worked to create a healthier, more equitable world in 2022

View all

May 18, 2023

Boston Scientific Announces €80M Investment and 400+ Jobs at Clonmel Site

Taoiseach Leo Varadkar joins company’s 25-year anniversary celebrations in Clonmel CLONMEL, IRELAND (19 May 2023) - Boston Scientific Corporation (NYSE: BSX) will today announce an €80 million...

Nov 29, 2022

Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.

Acquisition to expand endoluminal surgery portfolio and add differentiated technologies for endobariatric procedures MARLBOROUGH, Mass., Nov. 29, 2022 /PRNewswire/ -- Boston Scientific Corporation...

All Releases

Nov 8, 2022

Boston Scientific amplía su oferta de diagnóstico en Europa con el lanzamiento del sistema de monitor cardíaco insertable LUX-Dx™

MADRID, 8 de noviembre de 2022 - Boston Scientific ha anunciado hoy, a la comunidad médico-científica especializada, el lanzamiento en Europa del Sistema de Monitor Cardíaco Insertable (MCI)...

Sep 2, 2021

Boston Scientific lanza FAST: una nueva terapia para la estimulación de la médula espinal

MARLBOROUGH, Mass., 2 de septiembre, 2021- Boston Scientific (NYSE: BSX) anunció hoy el lanzamiento en Europa de la terapia FAST para sus sistemas de estimulación de la médula espinal (SCS)...

All Releases

Nov 8, 2022

Boston Scientific erweitert Diagnostikangebot in Europa mit der Einführung des implantierbaren Herzmonitorsystems LUX-Dx

Düsseldorf, 8. November 2022 – Die Boston Scientific Corporation (NYSE: BSX) gab heute die Markteinführung des LUX-Dx Insertable Cardiac Monitor (ICM) Systems in Europa bekannt. Das...

Feb 15, 2022

Boston Scientific schließt die Übernahme von Baylis Medical Company Inc. ab

MARLBOROUGH, Mass., 15. Februar 2022– Boston Scientific Corporation (NYSE: BSX) hat heute den Abschluss seiner Übernahme von Baylis Medical Company Inc. bekannt gegeben, einem Unternehmen, das...

All releases

Nov 8, 2022

Boston Scientific amplia l’attività diagnostica in Europa con il nuovo sistema di monitoraggio cardiaco inseribile LUX-Dx™

Milano, 8 novembre 2022 - Boston Scientific Corporation (NYSE: BSX) ha annunciato oggi l’introduzione in Europa del nuovo monitor cardiaco inseribile LUX-Dx™ (ICM), un dispositivo diagnostico...

Jun 21, 2022

Ripristinare funzioni vitali e qualità di vita dopo l’asportazione di un tumore alla prostata: le opzioni terapeutiche risolutive e sostenibili per l’incontinenza urinaria maschile

Ripristinare funzioni vitali e qualità di vita dopo l’asportazione di un tumore alla prostata: le opzioni terapeutiche risolutive e sostenibili per l’incontinenza urinaria maschile Milano, 21...

All Releases

Key Dates